Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Clinical Trial
Study findings presented on early stroke-type detection test
By
LabPulse.com staff writers
A new blood test may rapidly distinguish stroke type before people with stroke symptoms reach the emergency department, according to a preliminary study being presented at the American Stroke Association's International Stroke Conference 2025.
February 5, 2025
Oncocyte releases data on transplant rejection assay
By
LabPulse.com staff writers
Diagnostics developer Oncocyte has announced study data showing that its monitoring assay for kidney transplant rejection significantly reduces the time to diagnosis.
December 4, 2024
Large language models tapped for speeding up clinical trial enrollment in U.S.
By
Liz Carey
Meanwhile, the FDA envisions integrating more clinical trial activities into local healthcare facilities, roaming mobile research units, and through at-home lab testing kits.
November 19, 2024
Caris Life Sciences embarks on 10K-sample breast cancer biomarker analysis project
By
LabPulse.com staff writers
Caris will perform comprehensive molecular characterization of TAILORx tissue samples.
October 25, 2024
BioAffinity secures $2.7M to advance novel lung cancer diagnostic test
By
LabPulse.com staff writers
Texas-based bioAffinity Technologies has secured nearly $2.7 million at the close of a registered direct stock offering that it will use for general corporate purposes, including working capital, to advance its novel CyPath Lung test.
October 24, 2024
Twist Bioscience enters deal for $15M million cash upfront
By
LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered a deal with Xoma Royalty Corporation.
October 22, 2024
Multiregional clinical trial data on FDA watch for U.S. applicability
By
LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Qiagen ventures into chronic disease CDx
By
LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Accelerate Diagnostics completes preclinical trial for antimicrobial test system
By
LabPulse.com staff writers
Accelerate Diagnostics successfully completed the preclinical trial of its WAVE antimicrobial susceptibility testing system.
August 12, 2024
Invenio enrolls 1st patients in AI-based lung cancer image analysis study
By
LabPulse.com staff writers
Invenio Imaging has begun enrolling patients in a pivotal study of its artificial intelligence (AI)-based image analysis module for lung cancer.
August 9, 2024
FDA stops BioNTech MediLink study due to 'significant risks,' adverse events
By
LabPulse.com staff writers
Conducted in both the U.S. and China, the YL202 study aimed to evaluate the safety and tolerability of the ADC as a later-line treatment for some cancers.
June 18, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Page 1 of 19
Next Page